Nicole Dale

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

Read FDA’s AEMS Updated for Consolidated Adverse Event Monitoring
- Pharmacovigilance & Safety
- FDA
- Adverse Event Monitoring
- Pharmacovigilance
- Adverse Events
- Regulatory Submissions
- Pharma Regulation
- Regulatory & IP
- Pharma Policy
- Commercial Strategy
- Data Analysis
- Data Integrity
- Data Management
- Data Quality
- Electronic Data Capture
- Real-World Data
- Data Protection
- Digital Ecosystems
- AI Pharma
- AI and Automation
- AI & Machine Learning
- Medical Writers
- Medical Governance
- Documentation
- Commercialisation & Medical Affairs
- Labelling and Packaging
- Pharma Intelligence
- Oversight
- Clinical Research Organisations
- Clinical Data
- Clinical Evidence
- Technical Operations
- Quality
- Quality Assurance
- Pharmaceutical Compliance
- Transparency
- Health Surveillance
- Analytical Monitoring
- Patient Access
- Post-market
- Real-world Evidence
- Remote Monitoring
FDA’s AEMS Updated for Consolidated Adverse Event Monitoring
Read The UK’s AI Biosecurity Lab Puts Pharma at the Centre of Security
- Biosecurity
- AI governance
- Infectious Diseases and Vaccines
- Antimicrobials and Anti-infectives
- AI Pharma
- AI & Advanced Healthcare
- AI & Machine Learning
- AI Drug Development
- Machine Learning in Pharma
- LLMs in Pharma
- Pharma Intelligence
- Tech and Innovation
- Biotech
- Data Analysis
- Data Protection
- Research Data
- Health Surveillance
- Biomedical R&D
- pharma R&D
- Pharmaceutical R&D
- Oversight
- Pharma Policy
- Regulatory & IP
- Pharma Regulation
- MHRA
- Computational Biology
- Multiomics
- Research Informatics
- Research Funding
- Translational & Pre-clinical Research
- Preclinical Development
- Nonclinical Development
- AI vendor assessment
- AI vendor auditing
The UK’s AI Biosecurity Lab Puts Pharma at the Centre of Security
Read Can Agentic AI Strengthen Clinical Safety Monitoring?
- Adverse Event Monitoring
- Pharmacovigilance & Safety
- Clinical Data
- Adverse Events
- Pharmacovigilance
- Health Surveillance
- Patient Registries
- Immunology and Immunotherapy
- Next-gen Modalities
- AI in Clinical Trials
- Clinical Trial Design
- Clinical Trial Regulation
- Clinical Evidence
- Clinical Logistics
- Clinical Research Organisations
- Clinical Trial Sites
- Clinical Trial Strategy
- clinical trials
- Remote Clinical Monitoring
- Data Analysis
- Data Integrity
- Data Management
- Data Protection
- Data Quality
- Electronic Data Capture
- Real-World Data
- Real-world Evidence
- Post-market
- Medtech
- Biotech
- HealthTech
- Technical Operations
- Tech and Innovation
- AI Pharma
- AI governance
- AI vendor auditing
- AI vendor assessment
- AI and Automation
- AI Drug Development
- AI & Machine Learning
- Machine Learning in Pharma
- LLMs in Pharma
- Oversight
- Pharmaceutical Compliance
- Pharma Policy
- Patient Care
- Biostatistics
- Documentation
- Medical Writers
Can Agentic AI Strengthen Clinical Safety Monitoring?
Read Pharmacovigilance Trends Shaping Drug Safety Reporting in 2026
- Technical Operations
- Adverse Event Monitoring
- Pharmacovigilance & Safety
- Adverse Events
- Remote Monitoring
- Remote Clinical Monitoring
- AI vendor auditing
- AI vendor assessment
- AI Pharma
- AI & Machine Learning
- AI and Automation
- AI Drug Development
- AI in Clinical Trials
- AI governance
- Oversight
- Post-market
- Real-World Data
- Real-world Evidence
- Clinical Data
- Clinical Evidence
- Clinical Research Organisations
- clinical trials
- Clinical Trial Design
- Clinical Trial Strategy
- Data and Digital Health
- Data Integrity
- Data Protection
- Data Quality
- Electronic Data Capture
- Patient Registries
- Labelling and Packaging
- LLMs in Pharma
- Machine Learning in Pharma
- Clinicians
- Pharma Regulation
- Clinical Trial Regulation
- Global Regulatory Affairs
- Pharma Policy
- Harmonisation Standards
- Documentation
- Pharmaceutical Compliance
- Quality
- Digital Ecosystems
- Digital Health
- FDA
- European Medicinces Agency
- Health Surveillance
- Pharmacovigilance
Pharmacovigilance Trends Shaping Drug Safety Reporting in 2026